Search

A study from Memorial Sloan Kettering found that young patients ages 18 to 39 with early-onset cancer have an especially high risk of harboring inherited genetic (germline) mutations.

… Monday, June 22, 2020 A study from Memorial Sloan Kettering (MSK) found that young patients ages 18 to 39 with early-onset cancer have an especially high risk of harboring inherited genetic (germline) mutations. Results from this study were presented by Zsofia K. Stadler, MD , medical oncologist at MSK

A randomized clinical trial at Memorial Sloan Kettering Cancer Center (MSK) has shown that fecal microbiota transplants (FMTs) can reestablish the health-promoting bacteria that are often damaged by intense antibiotic treatment in people who have stem cell or bone marrow transplants for blood cancer.

… Friday, September 28, 2018 Bottom Line: A randomized clinical trial at Memorial Sloan Kettering Cancer Center (MSK) has shown that fecal microbiota transplants (FMTs) can reestablish the health-promoting bacteria that are often damaged by intense antibiotic treatment in people who have stem cell or bone

Take a short quiz to test your knowledge of breast cancer screening.

… Tuesday, October 3, 2017 Summary Does breast cancer screening hurt? How often should you get a mammogram? Get the answers to these questions and more by taking this quiz. It can be hard to stay on top of current breast cancer screening guidelines because the advice is sometimes confusing or conflicting

Memorial Sloan Kettering Cancer Center (MSK) is proud to announce that it is ranked among the top 20 organizations with the greatest number of highly cited scientific researchers worldwide, according to the annual list of Highly Cited Researchers published by the Institute for Scientific Information at Clarivate.

… Thursday, November 18, 2021 Memorial Sloan Kettering Cancer Center (MSK) is proud to announce that it is ranked among the top 20 organizations with the greatest number of highly cited scientific researchers worldwide, according to the annual list of Highly Cited Researchers published by the Institute

Visible Ink at Memorial Sloan Kettering Cancer Center (MSK) is the leading — and largest — writing program of its kind. Writing promotes creativity, reduces stress, and empowers people with cancer to give voice to their stories.

… Friday, April 6, 2018 Visible Ink at Memorial Sloan Kettering Cancer Center (MSK) is the leading — and largest — writing program of its kind. Writing promotes creativity, reduces stress, and empowers people with cancer to give voice to their stories. On Monday, April 16 at 6:30 p.m. , the Kaye Playhouse

Dr. Perales was formally sworn in during the 2023 Tandem Transplantation and Cellular Therapy Meetings of ASTCT and the Center for International Blood and Marrow Transplant Research (CIBMTR) on February 18.

… Monday, February 20, 2023 Miguel-Angel Perales, MD , of Memorial Sloan Kettering Cancer Center (MSK), has been named President of The American Society for Transplantation and Cellular Therapy (ASTCT) for 2023-2024. Dr. Perales was formally sworn in during the 2023 Tandem Transplantation and Cellular

Memorial Sloan Kettering Cancer Center (MSK) today celebrated the opening of a $1.5 billion state-of-the-art cancer treatment facility with government officials, members of the Boards of Overseers and Managers, and staff. Opening for patient care next month, the 750,000-square-foot building is the institution’s — and the city’s — largest freestanding cancer care facility. The David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center is a healing community dedicated to patient-centered care, made possible by a landmark donation and a pioneering vision that signifies a new era of cancer care.

… Tuesday, December 10, 2019 Memorial Sloan Kettering Cancer Center (MSK) today celebrated the opening of a $1.5 billion state-of-the-art cancer treatment facility with government officials, members of the Boards of Overseers and Managers, and staff. Opening for patient care next month, the 750,000-square-foot

Learn how MSK works to keep people with cancer heart healthy.

… Thursday, February 13, 2020 Summary People with cancer are at a significantly higher risk of heart disease during and after treatment. The issue has taken on more importance because people are living longer after a cancer diagnosis. Cancer is challenging enough on its own. Now, a recent study published

New MSK research supported the approval of a new treatment for ER-positive, HER2-negative advanced breast cancer; suggests a new strategy for overcoming resistance to Akt inhibitors in patients with PTEN-mutated prostate cancers; provides new understanding of B cell lymphomas that could lead to new treatments; examines using ChatGPT to help capture patient-reported outcomes; and developed the first customizable, scalable model for palliative care training for emergency departments.

… Thursday, February 13, 2025 New research from Memorial Sloan Kettering Cancer Center (MSK) supported the approval of a new treatment for ER-positive, HER2-negative advanced breast cancer; suggests a new strategy for overcoming resistance to Akt inhibitors in patients with PTEN -mutated prostate cancers

After treatment for rectal cancer, Roxanne Joseph is back to enjoying an active life with her husband, Rory, and their two children. Recent research by MSK computational biologist Henry Walch is shedding light on why colorectal cancer has been more difficult to treat in many Black people.

… Saturday, July 1, 2023 By Jim Stallard At first, Roxanne Joseph thought she was just hitting the gym weights too hard. The Brooklyn police officer was in top physical condition at age 41 and felt great. But after noticing blood in her stool, she remembered her uncle’s colorectal cancer diagnosis four